ACR appropriateness criteria® definitive therapy for early-stage cervical cancer

William Small, Jonathan B. Strauss, Anuja Jhingran, Catheryn M. Yashar, Higinia R. Cardenes, Beth A. Erickson-Wittmann, Norleena Gullett, Elizabeth Kidd, Larissa J. Lee, Nina A. Mayr, David Moore, Ajmel A. Puthawala, Gautam G. Rao, Mahesh A. Varia, Andrew O Wahl, Aaron H. Wolfson, William Yuh, David K. Gaffney

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Objectives: The definitive treatment of early-stage cervical cancer involves multidisciplinary decision making. This expert panel was convened to reach consensus on the selection of appropriate therapies based on patient and disease characteristics at presentation. Methods: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or the treatment. Results: Three clinical variants were developed to represent common scenarios in the treatment of early-stage cervical cancer. Group members reached consensus on the appropriateness of therapeutic options. This process yielded numerical ratings and descriptive commentary. Conclusions: This manuscript represents the consensus opinion of an expert panel based on a survey of all available medical literature. This manuscript may be used to inform the clinical decision making of physicians involved in the treatment of early-stage cervical cancer.

Original languageEnglish (US)
Pages (from-to)399-405
Number of pages7
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume35
Issue number4
DOIs
StatePublished - Aug 1 2012

Fingerprint

Uterine Cervical Neoplasms
Consensus
Expert Testimony
Therapeutics
Guidelines
Radiology
Decision Making
Physicians

Keywords

  • ACR
  • Appropriateness criteria
  • cancer
  • cervix
  • radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Small, W., Strauss, J. B., Jhingran, A., Yashar, C. M., Cardenes, H. R., Erickson-Wittmann, B. A., ... Gaffney, D. K. (2012). ACR appropriateness criteria® definitive therapy for early-stage cervical cancer. American Journal of Clinical Oncology: Cancer Clinical Trials, 35(4), 399-405. https://doi.org/10.1097/COC.0b013e3182610537

ACR appropriateness criteria® definitive therapy for early-stage cervical cancer. / Small, William; Strauss, Jonathan B.; Jhingran, Anuja; Yashar, Catheryn M.; Cardenes, Higinia R.; Erickson-Wittmann, Beth A.; Gullett, Norleena; Kidd, Elizabeth; Lee, Larissa J.; Mayr, Nina A.; Moore, David; Puthawala, Ajmel A.; Rao, Gautam G.; Varia, Mahesh A.; Wahl, Andrew O; Wolfson, Aaron H.; Yuh, William; Gaffney, David K.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 35, No. 4, 01.08.2012, p. 399-405.

Research output: Contribution to journalReview article

Small, W, Strauss, JB, Jhingran, A, Yashar, CM, Cardenes, HR, Erickson-Wittmann, BA, Gullett, N, Kidd, E, Lee, LJ, Mayr, NA, Moore, D, Puthawala, AA, Rao, GG, Varia, MA, Wahl, AO, Wolfson, AH, Yuh, W & Gaffney, DK 2012, 'ACR appropriateness criteria® definitive therapy for early-stage cervical cancer', American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 35, no. 4, pp. 399-405. https://doi.org/10.1097/COC.0b013e3182610537
Small, William ; Strauss, Jonathan B. ; Jhingran, Anuja ; Yashar, Catheryn M. ; Cardenes, Higinia R. ; Erickson-Wittmann, Beth A. ; Gullett, Norleena ; Kidd, Elizabeth ; Lee, Larissa J. ; Mayr, Nina A. ; Moore, David ; Puthawala, Ajmel A. ; Rao, Gautam G. ; Varia, Mahesh A. ; Wahl, Andrew O ; Wolfson, Aaron H. ; Yuh, William ; Gaffney, David K. / ACR appropriateness criteria® definitive therapy for early-stage cervical cancer. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2012 ; Vol. 35, No. 4. pp. 399-405.
@article{5cfc9968ed994ae4b8157c4a0f3625f3,
title = "ACR appropriateness criteria{\circledR} definitive therapy for early-stage cervical cancer",
abstract = "Objectives: The definitive treatment of early-stage cervical cancer involves multidisciplinary decision making. This expert panel was convened to reach consensus on the selection of appropriate therapies based on patient and disease characteristics at presentation. Methods: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or the treatment. Results: Three clinical variants were developed to represent common scenarios in the treatment of early-stage cervical cancer. Group members reached consensus on the appropriateness of therapeutic options. This process yielded numerical ratings and descriptive commentary. Conclusions: This manuscript represents the consensus opinion of an expert panel based on a survey of all available medical literature. This manuscript may be used to inform the clinical decision making of physicians involved in the treatment of early-stage cervical cancer.",
keywords = "ACR, Appropriateness criteria, cancer, cervix, radiotherapy",
author = "William Small and Strauss, {Jonathan B.} and Anuja Jhingran and Yashar, {Catheryn M.} and Cardenes, {Higinia R.} and Erickson-Wittmann, {Beth A.} and Norleena Gullett and Elizabeth Kidd and Lee, {Larissa J.} and Mayr, {Nina A.} and David Moore and Puthawala, {Ajmel A.} and Rao, {Gautam G.} and Varia, {Mahesh A.} and Wahl, {Andrew O} and Wolfson, {Aaron H.} and William Yuh and Gaffney, {David K.}",
year = "2012",
month = "8",
day = "1",
doi = "10.1097/COC.0b013e3182610537",
language = "English (US)",
volume = "35",
pages = "399--405",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - ACR appropriateness criteria® definitive therapy for early-stage cervical cancer

AU - Small, William

AU - Strauss, Jonathan B.

AU - Jhingran, Anuja

AU - Yashar, Catheryn M.

AU - Cardenes, Higinia R.

AU - Erickson-Wittmann, Beth A.

AU - Gullett, Norleena

AU - Kidd, Elizabeth

AU - Lee, Larissa J.

AU - Mayr, Nina A.

AU - Moore, David

AU - Puthawala, Ajmel A.

AU - Rao, Gautam G.

AU - Varia, Mahesh A.

AU - Wahl, Andrew O

AU - Wolfson, Aaron H.

AU - Yuh, William

AU - Gaffney, David K.

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Objectives: The definitive treatment of early-stage cervical cancer involves multidisciplinary decision making. This expert panel was convened to reach consensus on the selection of appropriate therapies based on patient and disease characteristics at presentation. Methods: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or the treatment. Results: Three clinical variants were developed to represent common scenarios in the treatment of early-stage cervical cancer. Group members reached consensus on the appropriateness of therapeutic options. This process yielded numerical ratings and descriptive commentary. Conclusions: This manuscript represents the consensus opinion of an expert panel based on a survey of all available medical literature. This manuscript may be used to inform the clinical decision making of physicians involved in the treatment of early-stage cervical cancer.

AB - Objectives: The definitive treatment of early-stage cervical cancer involves multidisciplinary decision making. This expert panel was convened to reach consensus on the selection of appropriate therapies based on patient and disease characteristics at presentation. Methods: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or the treatment. Results: Three clinical variants were developed to represent common scenarios in the treatment of early-stage cervical cancer. Group members reached consensus on the appropriateness of therapeutic options. This process yielded numerical ratings and descriptive commentary. Conclusions: This manuscript represents the consensus opinion of an expert panel based on a survey of all available medical literature. This manuscript may be used to inform the clinical decision making of physicians involved in the treatment of early-stage cervical cancer.

KW - ACR

KW - Appropriateness criteria

KW - cancer

KW - cervix

KW - radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84864339451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864339451&partnerID=8YFLogxK

U2 - 10.1097/COC.0b013e3182610537

DO - 10.1097/COC.0b013e3182610537

M3 - Review article

C2 - 22810416

AN - SCOPUS:84864339451

VL - 35

SP - 399

EP - 405

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 4

ER -